Skip to main content
. 2023 Jan 19;13(6):2715–2735. doi: 10.1016/j.apsb.2023.01.014

Figure 10.

Figure 10

PK properties of D10 and D15in vivo. (A) The mean plasma concentrations vs time in rats after administrated with D10, D15 and tepotinib via different routes (mean ± SD, n = 4). (B) The mean pharmacokinetic parameters in rats after administrated with D10, D15 and tepotinib via different routes (mean ± SD, n = 4). ∗P < 0.05, ∗∗P < 0.01 compared with tepotinib group via corresponding routes. ##P < 0.01 compared with D10 group via corresponding routes.